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1 Introduction
The achievements of Bangladesh in health
service delivery are now globally acknowledged
and have stirred global interest in the factors
that might have contributed to the achievements.
In their Lancet publication ‘Community-based
Approaches and Partnerships: Innovations in
Health-service Delivery in Bangladesh’, Arifeen
et al. (2013) attributed the success to three
factors: (1) application and adaptation of
community-based approaches and community
health workers at scale; (2) partnerships between
the government and non-state actors; and
(3) early and rapid adoption of innovations. The
success of Bangladesh is further attributed to
empowerment of women and the reach of the
NGOs (The Guardian 2013). Das and Horton
(2013) in their commentary ‘Bangladesh:
Innovating for Health’ in the Lancet identified
four factors: (1) the pluralism of the health-care
sector in Bangladesh; (2) the continued focus on
research; (3) increasing gender equity; and
(4) strengthened international cooperation.
An interesting point here is that the role of the
private sector is often discussed rather subtly in
the context of the pluralism in health service
delivery in Bangladesh. While discussing the
agenda of ‘Harnessing Pluralism for Better Health
in Bangladesh’, Ahmed et al. (2013) identified
the formal and informal aspects of the private
sector in health service delivery in Bangladesh.
Formal providers include high-end secondary to
tertiary level clinical service providers and
training institutes while informal providers
include the large cadre of village doctors, drug
shop attendants, homeopathic practitioners and
traditional medicine practitioners.
While these actors, who are directly involved in
health service delivery, will continue to be the
representatives of the private sector in health,
findings from a UK Department for International
Development (DFID) scoping study on innovations
in health service delivery in Bangladesh reveal
an emerging group of private sector actors who
might dictate transformation towards new
market systems in health services in Bangladesh.
Specifically, the scoping study highlighted that
new health models are based on an evolving form
of partnership between NGOs and the formal for-
profit private sector. A closer review of the models
further revealed what could be considered to be a
new form of health market systems in which the
formal for-profit private sector directly
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contributes to the conceptualisation, marketing
and financing of health services. The private
sector in these models includes not only private
health facilities and pharmaceutical companies
that play an active role in health provision, but
also manufacturers of fast-moving consumer
goods, telecommunication service providers,
technology start-ups, social businesses and
financial service providers.
But what makes these actors relevant in the
context of Bangladesh’s health systems? How are
they going to shape health systems interventions
in the future? What are their underlying
interests in playing these roles? Does this signal
a transformation to new market systems for
health service delivery? Can such new systems
deliver benefits for the poor? What role does the
government play in harnessing the development?
What are the implications of this development
on the design and management of health
systems projects in the future?
In this article the author reviews two cases from
Bangladesh that provide insights into these
evolving health market systems in which the
collaboration between NGOs and formal for-
profit private actors has played a key role in
stimulating innovations in health service
delivery. This is not a scientific paper but a
practitioner’s note that builds on the author’s
experience in designing, managing and
evaluating development interventions that can
deliver scalable and transformative impacts.
2 Key concepts
The case analyses presented here build on the
following concepts.
Innovation: Innovation in this article refers to
new, improved or previously untested approaches
in health service delivery. This includes
partnerships between state and non-state actors
in which actors engage in new forms of
collaboration based on mutual interest
(commercial or social). Such innovations in
service delivery are highly relevant for countries
like Bangladesh where about 47 million people
are estimated to be living below the poverty line
(Bloom et al. 2013b) and where the limited access
to health-care services has led to the evolution of
pluralistic health market systems in which
NGOs, informal providers and the private sector
dominate health services (Bloom et al. 2013a).
Health market systems: The author adopts the
concept of ‘market systems’ which is defined by
the Springfield Centre (2014) as ‘a multi-function
and multi-player arrangement comprising the
core function of exchange and the supporting
functions and rules which are performed and
shaped by a variety of market players’. The
concept ‘core function of exchange’ needs some
elaboration. Within a health system, different
types of exchange can take place. This includes
transactions in health services, health technologies,
health information, health-care financing,
medical education and so forth. Each of these
transactions is conceived of as taking place in a
specific market system – for instance, the health
service delivery market system, health
technologies market system and health financing
market system.
It is critical to note here that the functions and
roles of health systems actors change with respect
to the markets within which they operate. For
instance, the health service providers who are on
the supply side in the health service delivery
market are on the demand side in the market for
health education and skill development. The
financial service providers who undertake a
supporting function in the health service delivery
market are at the core of the exchange in the
health financing market. The author believes
that by deconstructing the broader health
systems into specific health market systems the
roles and functions of the market players and
their interconnectedness could be better
understood. The cases in this article are thus
analysed in the context of specific health market
systems rather than general health systems.
Financial viability/sustainability: In their report
on health sector reforms in low- and middle-
income countries, Knowles, Leighton and
Stinson (1997) defined financial sustainability as
the ‘capacity of the health system to replace
withdrawn donor funds with funds from other,
usually domestic, sources’ and sustainability of
an individual programme as the ‘capacity of the
grantee to mobilize the resources to fund the
recurrent costs of a project once it has
terminated’. While this is specific to externally
supported initiatives, given the nature of the
health systems markets discussed in this article,
the author uses these definitions here to assess
the financial sustainability of the models that are
reviewed.
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Transformative change: In relation to health
projects, systemic change deals with the question
‘what happens to the benefits provided by the
project after the project support is withdrawn?’
rather than only the direct and immediate
benefit to the targeted population. Systemic or
market systems change is defined by the
Springfield Centre (2014) as ‘a change in the
way supporting functions and rules perform that
ultimately improves the poor’s terms of
participation within the market system’. The
following example of the difference in high-level
outcomes between initiatives aimed at delivering
vital health services to the poor and initiatives
facilitating systemic change for the delivery was
highlighted by Engineers Without Borders
Canada (2014):
z Delivering vital health services: ‘Decreasing infant
mortality & improving maternal health in a
specific location over 5 years by training local
staff and holding perinatal and antenatal
clinics with mother care groups.’
z Systemic change in local health: ‘At the end of
5 years, public and private local clinics [across
a wide geographic area are] providing
affordable, high-quality maternal health
services to new and expecting mothers for the
foreseeable future, reducing infant mortality
over time.’
In this example, it is clear that in both scenarios,
the improvements will likely continue after
support is withdrawn. However, the improvements
in the first case will not necessarily spread beyond
the locality of intervention, and improvements in
services within this locality may or may not
continue once the trained staff retire or leave.
This leads to the next area of focus, related to
scale.
Within development interventions, the term
‘scaling up’ is generally used to refer to the
efforts undertaken by the project to achieve
‘scale’ (which often refers to the number of
people reached by an intervention). In the World
Bank (2003) working paper Scaling-up the Impact
of Good Practices in Rural Development, scaling up is
defined as ‘[an approach] to efficiently increase
the socioeconomic impact from a small to a large
scale of coverage.’ However, this definition does
not clarify whether the scale is being achieved by
the project itself or by the actors in the systems
supported by the project. If the project is the
main driver behind scaling up then there is a risk
that the scale is limited to the project’s funding
and effort. On the other hand, if the project
facilitates the conditions for other market
players to scale up then there is a chance that
the project can break through beyond its own
funding and efforts, thereby leading to a
transformative change.
To assess the promise of a development
intervention to deliver transformative change,
the author adopts the concept of ‘scalability’. In
this article, the author defines scalability as the
promise or the potential of a development
intervention to reach more people in a wider
geographic territory than originally targeted by
the project and includes impact that the
intervention can potentially achieve after the
project support is withdrawn.
3 Review of cases from Bangladesh
In this section, the author reviews two cases that
explore new forms of collaboration between the
non-profit and for-profit sectors and the
potential of these partnerships to deliver
systemic health market changes, considering
scalability, financial viability and pro-poor
benefits. The first case examines an innovation
which aims to address maternal and child health
issues by creating access to information on
prenatal and post-natal care through mobile
phones. The other case illustrates how one of the
largest NGOs in Bangladesh partnered with one
of the largest pharmaceutical companies in
Bangladesh to develop a viable model for rural
distribution of a micronutrient food supplement,
‘sprinkles,’ to tackle the problem of micronutrient
deficiency among children aged 6–23 months.
Case 1: Mobile phone technology and NGO
front-line health services merge to provide
prenatal and post-natal care information: the
case of Aponjon
Background: Walton and Schbley (2013)
reported a positive link between skilled prenatal
and post-partum education and improved
outcomes and decreased maternal morbidity and
mortality. Typically, the delivery of prenatal and
post-partum education relies on a health-care
system that can reach out to pregnant women
and mothers of newborns. But there is a
significant gap in access to such health care in
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Bangladesh. According to Koenig et al. (2007),
48 per cent of the respondents of a national
study conducted on 103,000 Bangladeshi female
subjects reported not receiving any type of
prenatal or post-partum health care. While not
addressing the lack of care, Aponjon, managed
by a social enterprise, Dnet, aims to address the
lack of prepartum and post-natal information
through a subscription-based service that
provides information to mothers and their
gatekeepers (for example husbands, mothers and
mothers-in-law of expectant or new mothers).
The service is designed to provide information on
prenatal and post-natal practices through instant
voice-recorded messages or Short Message
Service (SMS) (based on the preference of the
subscriber (Alam and Raihan 2014)). The service
was introduced in Bangladesh in September
2011, under the global public–private initiative
called Mobile Alliance for Maternal Action
(MAMA), and launched by the United States
Agency for International Development (USAID)
and Johnson & Johnson, in collaboration with the
United Nations Foundation, the mHealth
Alliance, and BabyCenter LLC (Rajan et al. 2013).
Significance of partnership in Aponjon:
Aponjon has a complex partnership arrangement
that includes NGOs, private sector and public
sector stakeholders. The partners in Aponjon
provide outreach, content development, content
regulation and financial support. Based on
available literature, the objectives and roles of
the different partners and their incentives in
Aponjon can be defined as below:
z Outreach: The NGOs and non-profit partners
provide outreach support for enrolment of
subscribers. Partners include BRAC, the
USAID NGO Health Service Delivery Project,
the USAID MaMoni Project, Fair Price
International Private Limited Company (Dnet
Infolady Social Entrepreneurship Programme),
the Social Marketing Company (SMC) and
Union Information and Service Centres
(UISCs) operated by the Access to Information
(A2I) programme under the Prime Minister’s
Office, Government of Bangladesh. The
health workers of the outreach partners, who
are called community agents, are trained by
the Aponjon programme and are provided cash
incentives for acquiring subscribers, data entry
and promotion through fairs and backyard
meetings (Dnet 2014). The ability to leverage
this large pool of community health workers in
Bangladesh could arguably be one of the
factors contributing to the transformation of
health systems in Bangladesh.
z Content development: A subsidiary of Dnet,
Multimedia Content and Communication
Limited (MCCL), manages the task of content
development. The content is based on
ethnographic research on a mother’s
awareness of government-circulated messages
related to pregnancy and childcare. Further to
that, the process involves review by an expert
panel consisting of Bangladeshi physicians,
researchers and communications professionals.
BabyCenter, an internationally recognised
web-based information service provider on
maternal and newborn care (see
www.babycenter.com), provides advisory support
for content development (Rajan et al. 2013).
z Content regulation and engagement of
government agencies: The roles of public
agencies in the partnership are twofold:
(1) regulation of content and the services
provided and (2) leveraging a public–private
partnership to achieve the government’s goal
related to promoting digital innovation and
development in agriculture, health, education
and governance systems in general. The
Bangladesh Ministry of Health and Family
Welfare (MoHFW) and the A2I programme
are the official government partners of
Aponjon. The MoHFW reviews and approves
the contents provided by Aponjon. The A2I
programme, as mentioned earlier, is one of
the outreach partners. Other public agencies
involved in outreach include the government’s
Community Clinic Project,1 the Directorate
General of Health Services (DGHS) and
Directorate General of Family Planning
(DGFP). Apart from these, the Bangladesh
Telecommunication Regulatory Commission
(BTRC) provides coordination support for
Aponjon to reach out to mobile phone
operators in Bangladesh.
z Financing: Aponjon has a strong focus on
corporate sponsorship for financing. USAID
and Johnson & Johnson provide seed financing
for 20 per cent of the costs of the Aponjon
initiative under the Maternal and Child
Health Integrated Programme (MCHIP) until
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June 2015. Additional corporate sponsors
include Beximco Pharma, one of the largest
pharmaceutical companies in Bangladesh,
Lal Teer Seeds Limited, one of the largest
agribusiness companies in Bangladesh and
Agora, the largest supermarket chain in
Bangladesh. 
Apart from financing, the corporate partners
are also engaged in promoting Aponjon
services. Beximco is promoting Aponjon
through its countrywide network of doctors.
Lal Teer Seeds promotes Aponjon in its leaflets,
calendars, posters, banners and signboards.
Agora is supporting a campaign called ‘Sponsor
a Mother’ under which a customer of Agora can
buy a token gift and sponsor a mother for a
total of 86 weeks. Dnet uses the funds
generated through this campaign to provide
free services to poor households who cannot
access the service for free.
z Knowledge management and international
outreach: The United Nations Foundation
provides support for communications,
advocacy and public outreach, and provides
linkages between the implementing agencies
of MAMA in Bangladesh, India and South
Africa. The mHealth Alliance serves as MAMA
Secretariat, and provides technical mhealth
expertise and a forum to exchange knowledge
and share best practices (Lemaire 2013).
Incentives of the partners: According to Dnet,
the partnership between the NGOs and Aponjon
is mutually beneficial: the NGOs benefit from
engagement of their community health workers in
income-generating activities through the
enrolment of the subscribers and through the sale
of products supplied by other partners, including
SMC, the largest supplier of contraceptives,
micronutrient powder (MNP) and safe delivery
kits in Bangladesh. As of June 2014, as many as
1,373 community health workers from BRAC were
engaged in enrolling subscribers for Aponjon in
101 upazillas of 16 districts in Bangladesh (see
www.aponjon.com.bd). This helps Aponjon save
costs in developing and maintaining a large pool
of outreach service providers across Bangladesh.
Aponjon also provides Dnet an opportunity to
generate revenue for its other concerns – for
instance, MCCL which is engaged in content
development.
By partnering with Aponjon, the Government of
Bangladesh is able to test the effectiveness of
public–private partnerships to achieve its goal of
creating a ‘digital Bangladesh and in [the]
context of health systems, test the effectiveness
of digital innovation on health outcomes’.
Corporate sponsors like Beximco benefit from
tax exemption due to their investment in
Aponjon under the corporate social responsibility
(CSR) agenda. Lal Teer Seeds has both CSR and
commercial benefit. By providing messages on
Aponjon on seed packets, Lal Teer is able to
position itself as a company having social
interest, which can potentially translate into
customer retention.
Most of the customers in Agora, the supermarket
chain that has partnered with Aponjon, are urban
women, the target group that generates a large
part of the revenue for Aponjon (further detailed
later in this case). Agora too is expected to benefit
from leveraging on the social or the CSR agenda.
However, the impact of CSR on corporate sales is
a subject that is yet to be researched.
Pathway towards transformative change –
prospects and challenges:
z Scalability: The case suggests that though the
service is being tested under a programme and
the primary (seed) funding is international aid,
the service is designed, tested, promoted and
scaled up by actors embedded in the market
systems. As per the definition of scalability
adopted for this article, an innovation is
scalable if the market players rather than the
project drive the effort towards achieving scale.
The project is run by Dnet, a social business and
therefore a market player which has the
commercial and social interest to continue the
service beyond the project’s tenure. Dnet is
supported by a band of outreach partners that
belong to the market systems of health
information, including NGOs and government
agencies. The partnership with local corporate
sponsors, who have become new actors in the
health information market systems, provides
the potential to evolve as increasing the
subscription base of Aponjon could potentially
attract more corporate sponsors who have a
similar strategic fit to sponsor Aponjon under
their CSR budget. Thus, Aponjon aims to
engage more corporate sponsors for rapid
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scale-up. The roles of government agencies and
international partners are also based on mutual
interest and are expected to continue beyond
the time frame (three years) for which the seed
financing is made available. The model thus
does have the potential to be scalable. But this
depends on the degree to which it is financially
viable once the seed financing is withdrawn.
This is further analysed below.
z Financial viability: The Aponjon service is
currently highly subsidised. The subscription
fee for each message (approximately 2.5 US
cents) is much lower than the development
cost per message (approximately 40 US cents;
Bloom et al. 2013b). However, the service is
expected to become self-sustaining once it
reaches the subscription base of 2 million
(ibid.). This means once it reaches the 2 million
subscriptions base, it will no longer require
financing through international aid or through
corporate financing. With around 60,000
subscribers added per month (data as of March
2014, as per GSMA 2014), and a current base
of 1.2 million subscribers, it is expected to
reach its stated target of 2 million and
therefore its financial viability by the end of
2015 (see www.mobilemamaalliance.org/mama-
bangladesh).
In addition, Aponjon is reportedly considering
development of an application through which
higher revenue generated from upper income
segments could be used to cross-subsidise the
basic service to the poorest mothers in
Bangladesh (see above website). It is also
adopting new and innovative mechanisms to
cut operating costs. Dnet has now introduced
mobile money for the financial management of
the community health workers under the
outreach partners and this has nearly halved
the cost of fund disbursement (Dnet 2014).
The model thus appears to be evolving with
the market by adopting new technologies and
service delivery models. From this account it
can be suggested that market-driven solutions
which continue to evolve as they mature
further increases the likelihood of becoming
financially viable.
z Reaching the poorest: The service of Aponjon is
not exclusively targeted for the poor.
According to Dnet, 41 per cent of its subscribers
are poor (average monthly household income
of BDT5,000–10,000). Around 5 per cent of
the subscribers belong to the poorest of the
poor category, having an average household
income of less than BDT5,000 per month.
Subscribers belonging to the lower middle-
income category (average monthly household
income of BDT10,001–20,000) are significant:
37 per cent of the total. The remaining 17 per
cent belong to the middle- and higher middle-
income categories. Moving forward, can
Aponjon increase its outreach to the poor?
The idea to tax subscribers belonging to the
upper category to cross-subsidise free services
to the poor suggests that there is a strategy in
place to maximise pro-poor outreach. But this
also suggests that market-driven solutions
might not be exclusively pro-poor. A risk here
could be that once the seed financing is
exhausted, the drive to sustain financial
viability might lead to rapid outreach to the
non-poor rather than the poor, thereby
offsetting the benefit to the poor. This is
nevertheless a hypothesis that needs to be
reviewed in the long run.
z Health outcomes: A survey undertaken to
assess the impact of the Aponjon service on
public health suggests positive outcomes. This
includes an increase in antenatal care (ANC)
visits (37 per cent of users compared to a 2011
national baseline of 26 per cent attending four
ANC visits), a relatively high rate of exclusive
breastfeeding (83 per cent of the new mothers
registered with Aponjon) and a high
immunisation rate of BCG (tuberculosis)
(96 per cent) and Pentavalet (100 per cent)
(Ahsan and Raihan 2013).
However, data on the contribution of Aponjon
towards national health outcomes is not yet
available. This is primarily because of the fact
that the service is relatively new in the health
system and has yet to become a driver at a
scale that can dictate national health
outcomes. But even in the long run, will it
have a positive impact on national health
outcomes related to maternal, newborn and
child health (MNCH)? If yes, at what scale
can it deliver such impact? Will it be possible
for Aponjon to achieve such scale on its own or
is there a requirement for renewed funding
and support from agencies that include the
government and possible expansion through
engagement of new providers? It would be
Sarwar Bangladesh Health Service Delivery: Innovative NGO and Private Sector Partnerships22
3 IDSB46.3 Sarwar.qxd  07/05/2015  13:25  Page 22
worthy to evaluate the impact of Aponjon in
the overall health systems in the long run to
ascertain its contribution in transforming the
health information market systems
specifically related to information for prenatal
and post-natal care.
Case 2: NGO–pharmaceutical company
collaboration for two-tier distribution ensures
rapid scale-up, pro-poor outreach and financial
viability for MNP: the case of Pushtikona
Background: Micronutrient malnutrition caused
largely by iron, iodine, vitamin A and zinc
deficiencies are common among young children
and lead to poor growth, impaired cognitive
development, susceptibility to infections and
diminishing economic outcomes during
adulthood (Afsana et al. 2014). As per findings
from the Bangladesh Demographic and Health
Survey 2011, 51 per cent of children aged 6–23
months are suffering from anaemia (NIPORT
et al. 2013). The National Micronutrient Survey
(2011–12) recorded a zinc deficiency at a
prevalence of 44.6 per cent among preschool
aged children. Based on a study from 2006, the
National Micronutrient Survey (2011–12)
estimates that about 19.6 per cent of young
children are suffering from vitamin A deficiency.
Pushtikona is a brand name of a micronutrient
‘sprinkles’ powder that contains 15 essential
minerals and vitamins that are intended to
improve the nutritional value of complementary
foods (see www.pushtikona.com). The product is
being marketed under the Bangladesh Sprinkles
Programme (BSP), which started in 2009 as a
collaborative effort between Renata Limited, a
leading pharmaceutical company in Bangladesh,
BRAC, the leading NGO in Bangladesh, and the
Global Alliance for Improved Nutrition (GAIN).
Originally developed by the Sprinkles Global
Health Initiative (SGHI), one of the technical
partners of the project, the product ‘Pushtikona’
was introduced for the prevention of anaemia
due to iron deficiency, growth retardation due to
zinc deficiency and gastrointestinal infections
related to deficiencies in vitamin A and other
nutrients (see www.pushtikona.com).
Significance of partnerships in Pushtikona:
The partners include Renata Limited, one of the
leading pharmaceutical companies in
Bangladesh, BRAC and GAIN. In the new phase
of the programme, ICDDR,B (International
Centre for Diarrhoeal Disease Research,
Bangladesh) and the Government of Bangladesh
are being engaged (see www.gainhealth.org).
This review is, however, limited to the partners
and the partnership of the last phase, given that
the scope of the new partners could not be
validated through secondary research.
Manufacturing: Renata Limited invested in the
production facility and manufactures the product
in line with World Health Organization (WHO)
recommendations (GAIN 2012). The investment
from Renata on manufacture and marketing of
the product can be associated with the fact that
the majority of the share of Renata is owned by
Sajida Foundation, one of the leading NGOs in
Bangladesh which focuses on public health and
poverty alleviation (ibid.).
Distribution; pro-poor outreach: The model
involves a two-tier distribution channel: (1) a
commercial channel that builds on Renata’s
national network covering 90 per cent of the
pharmacies in Bangladesh (GAIN 2012); and
(2) an institutional channel that builds on
BRAC’s cadre of 97,000 community health
workers called Shasthya Sebikas (Afsana et al.
2014) and reaches out the bottom of the pyramid
to the poorest of the poor population. In the
commercial channel, Renata distributes the
product for BTK2.50 (3 US cents) per sachet
through a network of about 1,100 medical
representatives reaching out to around 50,000
doctors across Bangladesh (Bloom et al. 2013b).
In the institutional channel BRAC purchases the
product for BTK1.55 (1.9 US cents) per sachet
and distributes it through its band of community
health workers who sell the product for a
minimum profit (margin unknown) (GAIN 2012).
Currently, BRAC is distributing the MNP in
61 districts (463 sub-districts) of Bangladesh
through its community health workers (Afsana et
al. 2014). BRAC implements the intervention in a
more intensive way with complementary feeding
practices in 50 districts under the Alive and
Thrive initiative supported by the Bill and
Melinda Gates Foundation (BMGF) with
leadership from Family Health International 360.
BRAC also distributes part of the product to ultra-
poor households under BRAC’s Ultra-Poor
Programme (Bloom et al. 2013b). In 2012, BRAC
distributed 16 per cent of its total volume of MNP
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to the children of ultra-poor households free of
cost (Afsana et al. 2014).
Marketing: Because of the distinct capacities of
Renata and BRAC, the partnership offers
demand creation approaches that could be
tailored to the need of the urban and the rural
market (GAIN 2012). While Renata focuses on
its experience in advertising campaigns, BRAC
builds on its experience in behavioural change
communications and also transfers knowledge
about the use of the product through its cadre of
community health workers (Afsana et al. 2014).
Quality control: It is not clear from available
literature what role the government has in
controlling the quality of the MNP, although it
does suggest that the product is manufactured as
per WHO guidelines (GAIN 2012). However, for
the MNP to effectively reduce deficiencies, a child
must be given a minimum of 60 single-dose
sachets with no more than one sachet a day over
60 days. Following this, 60 sachets should be
consumed every six months until a child’s
haemoglobin levels rise above the cut-off for
anaemia. In the institutional channel, BRAC’s
health workers monitor compliance, and the
programme has acknowledged that ensuring
children consume the minimum dosage is a
challenge that is still to be addressed (Afsana et
al. 2014). However, there is no formal account of
monitoring in the commercial channel.
Financing: GAIN invested US$3 million with
funding from the BMGF in the first phase of the
programme (2009–13). The financing from
GAIN in the first phase was used on a cost-
sharing basis to provide technical assistance and
to support Renata in establishing the production
facilities and marketing the product. GAIN also
provided funding to BRAC to train community
health workers (Bloom et al. 2013b). The
programme has now entered a new phase
(2013–18) with a US$27.5 million grant from the
Children’s Investment Fund Foundation (CIFF)
(see www.cooperationinternationalegeneve.ch).
The financial viability of the model is further
analysed in the subsequent section of this case.
Incentives of the partners: The two-tier
distribution system is mutually beneficial for
Renata and BRAC. Renata gains from an
assured institutional market reached through
BRAC, the institutional buyer. On the other
hand, BRAC has two main incentives: (1) it can
leverage the partnership to achieve deeper
health impacts through its complementary
feeding initiatives; and (2) the partnership
provides BRAC with an opportunity to create
income-generating opportunities for its large
cadre of community health workers.
Health impact: The Alive and Thrive initiative
focused on breastfeeding and complementary
feeding and a preliminary evaluation (IFPRI
2013) suggests a number of improvements in
infant and young child feeding (IYCF) practices
as a result of the overall initiative. However, the
report does not provide data specifically related
to the MNP to indicate the effectiveness of the
initiative in reducing micronutrient deficiencies.
Thus, there is a need to assess the impact
achieved by distribution of sprinkles in
programme areas apart from Alive and Thrive.
This would provide a critical understanding of
the impact on micronutrient deficiency that
could be achieved through the use of
micronutrient sprinkles.
Pathway towards transformative change –
prospects and challenges
z Scalability: In terms of scale, production has
steadily increased over the period 2009–13
and in 2013, Renata produced nearly
34 million sachets of MNP, of which about
14.5 million sachets were distributed through
the delivery networks of BRAC’s community
health workers (Afsana et al. 2014). The
simultaneous focus on urban and rural
markets and the distinctive capacities of
BRAC and Renata means that the partners
are not cannibalising each other’s market and
can expand the market base. The programme
was expected to benefit 6.8 million children
under the age of two, though available
literature does not provide an account of the
number of children reached.
However, in terms of scalability, a key point to
note is that in this model, GAIN works as
central to the coordination between BRAC
and Renata for the distribution of the
commodities through different channels.
Thus, unlike the Aponjon model where a
market player is tasked to manage the system,
in the Pushtikona model a pseudo or a
temporary market player like GAIN is leading
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the management system. This is against the
principle of scalability since the relationship
between the market players and therefore the
continuity of the model could be threatened
once GAIN withdraws itself from the system.
z Financial viability: While it is evident that the
partnership between BRAC and Renata is
mutually beneficial, whether the partnership
can continue without financial assistance is a
question to be answered. However, the model
is not entirely dependent on aid finance, since
Renata co-invested on the programme and
markets the product through its own channel
in addition to that of BRAC. The literature
suggests that the donor financing is primarily
used for rural outreach which involves
investment for training of community health
workers as the model is scaled up to reach
more people. From these accounts we can
assume that the urban component managed
by Renata is not dependent on aid. However,
the rural component of the programme
depends on subsidy and free distribution to
the poor. The renewed funding of
US$27 million is a testimony to the fact that
the model is yet to become a significant
market force on its own to be able to achieve
its full potential without further development
assistance. Review of the degree to which the
programme is benefiting the poor provides
further insight into the challenges that call
for continued development assistance. Also,
from the review of the literature the author
was not able to determine whether there is a
plan to cross-subsidise the rural distribution
through revenue generated by Renata from
the commercial distribution. It can
nevertheless be stated that the prospect for
cross-subsidisation is low since the two
systems are operated by two different entities.
z Reach to the poorest: Review of the existing
literature on the model reveals two challenges
with respect to scalable pro-poor outreach.
Firstly, according to BRAC there is still a need
to review the incentives of the front-line
health workers and the pricing structure to
keep the product within the reach of the
targeted population (Afsana et al. 2014). This
suggests that the income from the sales of the
product is not at the level to incentivise the
community health workers to push the
product to the market at scale. Secondly,
ultra-poor outreach is dependent on free
distribution by BRAC and is therefore yet to
become market-led. BRAC is yet to test a
model whereby revenue generated by
distribution to the wealthier class in the rural
markets could be used to fund the distribution
to the ultra-poor.
Further, rural distribution is dependent on
BRAC’s community health workers and a
subsidy on the wholesale price. It is not clear
how the subsidy is financed and whether the
subsidy is borne by BRAC through external
funding. A review undertaken by BRAC
suggests the need for further efforts to
increase the knowledge of mothers and care
givers, increase compliance to dosage
requirements and change cultural norms
related to home-based feeding practices for
children. It thus appears that the model might
face difficulties with respect to pro-poor
outreach if it is left to the market at this stage.
4 Discussion and conclusions
The review of these two cases reveals a number
of interesting insights related to health market
system interventions with respect to partnerships,
financial viability and pro-poor benefits.
Related to partnerships, in both of the cases
reviewed, partners were involved from the public
and private sectors across different market
systems. The cases reviewed suggest that synergy
of incentives of the partners is a key determinant
of partnerships. In both models, partners have
mutually reinforcing incentives which make the
partnerships work. The cases also suggest that
the partnerships are being built on developments
in different market systems: the NGO health
service delivery system, the pharmaceuticals
market systems and the telecommunications
market system. This suggests a need to
understand the potential interconnectedness of
market systems beyond those specifically related
to health to determine the factors that could
drive transformative change.
It is also noteworthy to mention that achieving
transformative market changes (i.e. crowding in)
may be against the interest of a company involved
in the innovation. If achieving market systems
changes is a key aim, then it might necessitate
the involvement of a third party. The Pushtikona
model in this respect has better potential for
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transformative change than the Aponjon model
where Dnet has disincentive (being a commercial
provider by itself) to allow more market players
to adopt the same innovation for service delivery.
However, the dependence on GAIN in the
Pushtikona case potentially undermines the
sustainability of the model. Surprisingly, both
initiatives are silent about the role of the
Bangladeshi government in sustaining efforts or
stimulating systemic change.
Financial viability was a significant issue for
these case studies. The cases reviewed suggest
three forms of financing that development aid
could leverage for financial viability of health
programmes: (1) corporate sponsorship in which
a for-profit company provides cash or in kind
support under the banner of CSR; (2) cross-
subsidy in which revenue generated from a
profit-making channel could be used to subsidise
a non-profit-making channel targeting the poor;
and (3) funding provided through a development
initiative to get the market solution to a point at
which it is self-sustaining. This third avenue may
or may not be delivered via match funding, in
which a for-profit company co-invests to develop
the scheme. More work would be needed to
compare the situations under which these forms
of financing can result in viable pro-poor market
systems changes in the health-care sector in
Bangladesh.
The cases also suggest that market solutions
might not be exclusively pro-poor. In both cases,
the business models reach out to both poor and
non-poor beneficiaries, and these dual markets
appear to be key to the viability of the initiatives,
even where cross-subsidy is not taking place (for
example, in the case of micronutrient sprinkles).
This might be an indication that market-driven
solutions might fail to deliver if designed
exclusively for the poor. However, this also raises
the risk that once the donor funding is pulled
out, market-driven solutions could be driven
away from the poor if the financial viability and
scalability of pro-poor outreach is not sustained
within the time frame for which the donor
support is available.
In terms of the actual impacts experienced by
the poor, none of the cases reviewed provide a
clear analysis of contribution of the models to
national or regional health outcomes. The
monitoring and evaluation system of
programmes assess the reach of the programmes
(in the case of Aponjon, the number of expectant
mothers and mothers of newborns receiving the
message and in the case of Pushtikona, the
number of children receiving the MNP), but are
lacking in measurement of the real changes in
people’s health or wellbeing and also in the
extent to which systemic changes are occurring.
Finally, it is worth noting that the cases reviewed
here were similar in a number of ways. Both are
based on the sale of a product or service to the
poor. They are also similar in that they leveraged
the large pool of community health workers in
Bangladesh, and involve the support of a non-
profit organisation. However, not all market
systems initiatives will take this approach or
have these resources to leverage. Thus, in
addition to deepening the research on these two
cases as more information becomes available,
expanding this analysis to other health market
interventions could yield interesting insights
about the potential for such initiatives to achieve
viability and scalability while also continuing to
reach and impact on the poor.
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Note
1 The title of the project is ‘Revitalization of
Community Health Care Initiatives in
Bangladesh’.
3 IDSB46.3 Sarwar.qxd  07/05/2015  13:25  Page 26
References
(All websites accessed 6 March 2015)
Afsana, K.; Haque, R.M.; Sobhan, S. and Shahin,
S.A. (2014) ‘BRAC’s Experience in Scaling Up
MNP in Bangladesh’, Asia Pacific Journal of
Clinical Nutrition 23.3: 377–84
Ahmed, S.M.; Evans, T.G.; Standing, H. and
Mahmud, S. (2013) ‘Harnessing Pluralism for
Better Health in Bangladesh’, in ‘Bangladesh:
Innovation for Universal Health Coverage 3’,
Lancet 382: 1746–55
Ahsan, A. and Raihan, A. (2013) ‘Understanding
mHealth Impact among Aponjon (MAMA
Bangladesh) Subscribers through a Phone
Survey in Bangladesh’, in ICTD 13 Proceedings
of the Sixth International Conference on Information
and Communications Technologies and Development:
Notes 2, New York NY: ACM
Alam, M. and Raihan, A. (2014) Assessing the
Impact of Mobile Health Messages among Expectant
Women and New Mothers – Case Study Aponjon,
Aponjon: USAID
Arifeen, S.E.; Christou, A.; Reichenbach, L.;
Osman, F.A.; Azad, K.; Islam, K.S.; Ahmed, F.;
Perry, H.B. and Peter, D.H. (2013) ‘Community-
based Approaches and Partnerships: Innovations
in Health-service Delivery in Bangladesh’, in
‘Bangladesh: Innovation for Universal Health
Coverage 3’, Lancet 382: 2012–26
Bloom, G.; Kanjilal, B.; Lucas, H. and
Standing, D.H. (2013a) Transforming Health
Markets in Asia and Africa: Improving Quality and
Access for the Poor, London: Routledge
Bloom, G.; Sarwar, R.: Standing, H.; Begum, T.;
Rahman, S. and Wilkinson, A. (2013b)
Innovations for Health in Bangladesh, Dhaka:
SRIJON
Das, P. and Horton, R. (2013) ‘Bangladesh:
Innovating for Health’, in ‘Bangladesh:
Innovation for Universal Health Coverage 3’,
Lancet 382.9906: 1681–82
Dnet (2014) Mobile Money Case Study: A Comparison
between Cash and Mobile Payments in Dnet’s




Engineers Without Borders Canada (2014)
Shifting Aid Models to Manage for Systemic Change,
Engineers Without Borders Canada Briefing
Paper, http://pollengroup.org/?p=18
GAIN (2012) A Child’s Daily Nutrition Within a





GSMA (2014) Snapshot: MAMA in Bangladesh:




IFPRI (2013) Alive & Thrive Process Evaluation
Report 2013: Preliminary Report, Dhaka:
International Food Policy and Research
Institute 
Knowles, J.C.; Leighton, C. and Stinson, W.
(1997) Measuring Results of Health Sector Reform
for System Performance: A Handbook of Indicators,
Special Initiatives Report 1, Bethesda MD:
Abt Associates, Partnerships for Health
Reform Project
Koenig, Michael A.; Jamil, K.; Streatfield, P. et al.
(2007) ‘Maternal Health and Care-Seeking
Behavior in Bangladesh: Findings from a
National Survey’, International Family Planning
Perspectives 33.2
Lemaire, J. (2013) Scaling up Mobile Health:
Developing mHealth Partnerships for Scale,
Geneva: Advanced Development for Africa
NIPORT (National Institute of Population
Research and Training), Mitra and Associates,
and ICF International (2013) Bangladesh
Demographic and Health Survey 2011, Dhaka,
Bangladesh and Calverton MD: NIPORT,
Mitra and Associates, and ICF International
Rajan R.; Raihan, A.; Alam, M.; Agarwal, S.;
Ahsan, A.; Bashir, R.; Lefevre, A.; Kennedy, C.
and Labrique, A.B. (2013) MAMA ‘APONJON’
Formative Research Report, Baltimore MD: Johns
Hopkins University Global mHealth Initiative
Springfield Centre (2014) The Operational Guide
for Making Markets Work for the Poor (M4P)
Approach, Durham: Springfield Centre
The Guardian (2013) ‘Healthcare in Bangladesh
Soars Despite Widespread Poverty, Study
Shows’, 21 November, www.theguardian.com/
global-development/2013/nov/21/bangladesh-
healthcare-poverty-lancet-study
Walton, L.M. and Schbley, B. (2013) ‘Maternal
Healthcare in Bangladesh and Gender Equity:
A Review Article’, Online Journal of Health
Ethics 9.1, http://aquila.usm.edu/cgi/
viewcontent.cgi?article=1047&context=ojhe 
WHO (2011) mHealth: New Horizons for Health
through Mobile Technologies – Based on the Findings
of the Second Global Survey on eHealth, World
IDS Bulletin Volume 46  Number 3  May 2015 27
3 IDSB46.3 Sarwar.qxd  07/05/2015  13:25  Page 27
Health Organization Global Observatory for
eHealth Series Volume 3, www.who.int/goe/
publications/goe_mhealth_web.pdf
WHO (2010) Health System in Bangladesh,
http://www.ban.searo.who.int/en/Section25.htm
World Bank (2003) Scaling-up the Impact of Good
Practices in Rural Development: A Working Paper to
Support Implementation of the World Bank’s Rural
Development Strategy, World Bank Agriculture and
Rural Development Department Report
26031, Washington DC: World Bank
Sarwar Bangladesh Health Service Delivery: Innovative NGO and Private Sector Partnerships28
3 IDSB46.3 Sarwar.qxd  07/05/2015  13:25  Page 28
